General Court confirms likelihood of confusion between pharma marks
In Bionecs GmbH v OHIM, the General Court has upheld a decision of the OHIM Board of Appeal finding that there was a likelihood of confusion between the word marks BIONECS and BIONECT for goods in Class 5. Among other things, the court held that the goods covered by the marks fell within the field of health, and that the board had been right to find that the nature and purpose of the goods were the same.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the WTR experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10